Learn about the science behind our innovative regenerative medicine and immunotherapy platforms here at Creative Medical Technology Holdings, Inc.
Morbi eget faucibus et sit aonec mauris metus facilisis adipiscing ante a massa pharetra elementum dignissim arcucol.
Composed of Perinatal Derived Tissue Cells
Immediately available allogenic cell line
The immunomodulatory properties help to treat immune, endocrine, and multiple other based disorders
White blood cells (including Treg cells) will be collected from the patient and undergo centrifugation.
The patient’s own white blood cells are then supercharged in the lab with stimulated donor cells.
The patient’s cultured cells continue to further expand.
The patient’s supercharged cells are infused back into the body.
Take adult cells (skin or blood) and mix with reprogramming factors to create iPSCs.
The iPSCs are further differentiated into any human cell type.
Harvested stem cell product contains endothelial progenitor cells, hematopoietic and mesenchymal cells with dilution or contamination of blood.
No rejection or immunosuppression required as the cells are autologous. Cells help to stimulate natural healing, improve muscle tissue, and promote increased blood flow.
The company benefits from an experienced management team as well as a base of talented scientific & medical consultants with vast industry experience.
Our innovative technologies are disruptive in the field of regenerative medicine.
We are looking forward to connecting!
Interested in learning more?Connect with us now by filling out our form on the contact page.